Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Percy Lee

Showing results (101-110 of 199) with videos related to

Pageof 20
Sort By:
Clinical Neurology and Neurosurgery|February 8, 2018
Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysisThien Nguyen, Courtney Duong, John P Sheppard, et al.
The British Journal of Radiology|November 23, 2017
Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRTDavid H Thomas, Anand Santhanam, Amar U Kishan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2011
Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scansZachary Zumsteg, John DeMarco, Steve P Lee, et al.
Medical Physics|March 4, 2016
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy systemYingli Yang, Minsong Cao, Ke Sheng, et al.
Advances in Radiation Oncology|July 26, 2017
Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinomaKiri A Sandler, Darlene Veruttipong, Vatche G Agopian, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
The British Journal of Radiology|January 13, 2017
Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancerNarek Shaverdian, Yingli Yang, Peng Hu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2021
Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLCAhsan Farooqi, Ethan B Ludmir, Kyle G Mitchell, et al.
Advances in Radiation Oncology|April 26, 2021
Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy SystemPhillip E Chow, Fang-I Chu, Nzhde Agazaryan, et al.
Pageof 20

Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
Clinical Neurology and Neurosurgery|February 8, 2018
Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysisThien Nguyen, Courtney Duong, John P Sheppard, et al.
The British Journal of Radiology|November 23, 2017
Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRTDavid H Thomas, Anand Santhanam, Amar U Kishan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2011
Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scansZachary Zumsteg, John DeMarco, Steve P Lee, et al.
Medical Physics|March 4, 2016
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI-guided tri-cobalt 60 radiotherapy systemYingli Yang, Minsong Cao, Ke Sheng, et al.
Advances in Radiation Oncology|July 26, 2017
Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinomaKiri A Sandler, Darlene Veruttipong, Vatche G Agopian, et al.
Clinical Lung Cancer|June 28, 2011
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerPercy Lee, Jose G Bazan, Philip W Lavori, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
The British Journal of Radiology|January 13, 2017
Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancerNarek Shaverdian, Yingli Yang, Peng Hu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2021
Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLCAhsan Farooqi, Ethan B Ludmir, Kyle G Mitchell, et al.
Advances in Radiation Oncology|April 26, 2021
Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy SystemPhillip E Chow, Fang-I Chu, Nzhde Agazaryan, et al.
Pageof 20